Hologic Forecast, price target & analysts
Hologic Target price 2025 - Analyst rating & recommendation
Hologic Classifications & Recommendation:
Hologic Price Target
| Target Price | $72.42 |
| Price | $67.99 |
| Potential |
6.52%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Hologic 2026 .
The average Hologic target price is $72.42.
This is
6.52%
register free of charge
$84.00
23.55%
register free of charge
$65.65
3.44%
register free of charge
|
|
| A rating was issued by 28 analysts: 12 Analysts recommend Hologic to buy, 15 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hologic stock has an average upside potential 2026 of
6.52%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.03 | 4.16 |
| 0.00% | 3.12% | |
| EBITDA Margin | 24.80% | 32.53% |
| 3.13% | 31.18% | |
| Net Margin | 19.59% | 22.81% |
| 73.14% | 16.44% |
24 Analysts have issued a sales forecast Hologic 2025 . The average Hologic sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Hologic EBITDA forecast 2025. The average Hologic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Hologic Analysts have issued a net profit forecast 2025. The average Hologic net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.32 | 4.27 |
| 81.42% | 28.61% | |
| P/E | 15.94 | |
| EV/Sales | 3.79 |
25 Analysts have issued a Hologic forecast for earnings per share. The average Hologic EPS is
This results in the following potential growth metrics and future valuations:
Current Hologic Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 31 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 31 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
| Needham |
Locked
➜
Locked
|
Locked | May 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 06 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 31 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 31 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 09 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 08 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
May 28 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
